Transcripts

CorMedix (CRMD) earnings call transcripts

Earnings call transcripts for CorMedix Inc., with a summary, the guidance given, and what analysts pressed on.

Open CRMD in Gloom →
CorMedix's chart, financials and news, free in your browser.Open CRMD in Gloom →
  • Q2 2026 earnings call

    Management framed the quarter around navigating the reimbursement transition, expanding DefendCAT access, and advancing Reseo while preserving flexibility on investment and guidance.

    Aug 13, 2026Positive0.68
  • Q3 2025 earnings call

    Management framed the quarter as a rapid integration and portfolio expansion story, while emphasizing DefenCath growth and upcoming non-dialysis catalysts.

    Nov 12, 2025Confident0.72